ake on a greater defense role. Against this backdrop, Japan adjusted its security policies to align with its evolving role within the alliance. Domestically, Japan is facing cha
强劲，弥补了上述缺口。公司抗癌药业务本季度销量同比增长超 22%。相比部分未来几年将面临更严重专利悬崖的同行，强生所处处境更为稳健。 与多年来的常态一致，强生制药业务贡献了公司大部分营收与增长。创新药销售额增长 11.2%，至 154.3 亿美元。与此同时，受多款心脏病医疗器械热销带动，一季度医疗器械业务销售额增长 7.7%，至 86.4 亿美元。 沃尔克表示：“医疗器械业务一季度表现存在一定
nbsp; Recently, Chen Zilei, president of the Shanghai Association for Japanese Studies and director of the Japanese Economic Research Cente at Shanghai University of International Business and Ec
当前文章：http://vbcfc.wenkepu.cn/1ui/i2jepbd.html
发布时间：10:07:36